CONNECT WITH US
HealthTech

HealthTech

Marijuana for insomnia? What the latest evidence says

Medical Xpress logo

Published on

Add as a preferred source on Google
Marijuana for insomnia? What the latest evidence says

This article has been reviewed according to Science X's editorial process and policies. Editors have highlighted the following attributes while ensuring the content's credibility:

If you struggle with insomnia, could medical marijuana help you get a better night's sleep?

A new Cochrane review on medical marijuana for insomnia shows little to no benefit for sleep quality or total sleep time, but researchers say there's not enough quality data to draw any firm conclusions.

Today, one in three adults worldwide have insomnia symptoms, and about 10% have chronic insomnia.

Researchers say existing treatments don't work equally well for everyone, fueling interest in alternatives like medical marijuana.

They analyzed nine clinical trials involving 537 adults with insomnia. Compared with placebo, medical marijuana showed little to no meaningful improvement in sleep quality, total hours slept or daytime functioning.

Medical marijuana may also increase the risk for side effects like dizziness and dry mouth, according to the results.

However, "this does not mean that medical cannabis is ineffective," lead author Dr. Lucia Varela, from the University of Manitoba in Winnipeg, Canada, said in a press release.

"The evidence is too weak and uncertain to draw firm conclusions about the use of medical cannabis for insomnia," added senior author Luis Garegnani, from University Hospital Italiano de Buenos Aires in Argentina.

The problem? Most available studies were small, short and tested different cannabis products. The researchers say larger, longer studies are needed to determine whether medical cannabis is an effective and safe treatment for insomnia.


Source link

Disclaimer

We strive to uphold the highest ethical standards in all of our reporting and coverage. We TheMorningPulse.fyi want to be transparent with our readers about any potential conflicts of interest that may arise in our work. It's possible that some of the investors we feature may have connections to other businesses, including competitors or companies we write about. However, we want to assure our readers that this will not have any impact on the integrity or impartiality of our reporting. We are committed to delivering accurate, unbiased news and information to our audience, and we will continue to uphold our ethics and principles in all of our work. Thank you for your trust and support.